human ca125 elisa kit Search Results


elisa kit  (R&D Systems)
93
R&D Systems elisa kit
Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Human+CA125%2FMUC16+Quantikine+ELISA+Kit/pmc12506169-45-6-10
Average 93 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
human ca125 elisa kit  (Elabscience Biotechnology)
93
Elabscience Biotechnology human ca125 elisa kit
Serum <t>CA125,</t> HE4, and CA72-4 ELISA analyses in patients with OvEndo and CTR. Blood samples were collected from each patient group included in the study, OvEndo and CTR, in non-heparinized tubes and centrifugated. Serum samples concentrations were performed for each marker, CA125, HE4, and CA72-4. CA: Cancer antigen; CTR: Control; ELISA: Enzyme-linked immunosorbent assay; HE4: Human epididymis 4; OvEndo: Ovarian endometriosis
Human Ca125 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Human+CA125+(Carbohydrate+Antigen+125)+ELISA+Kit/pmc10520369-68-4-8
Average 93 stars, based on 1 article reviews
human ca125 elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
ca125 elisa kit  (R&D Systems)
94
R&D Systems ca125 elisa kit
Performance of (A) Mercy Halo biomarker combination <t>FOLR1/MUC16,</t> (B) Mercy Halo biomarker combination BST2/FOLR1/MUC16, and (C) <t>CA125</t> ELISA in a cohort of healthy controls (n=24), patients with benign ovarian masses (n=26), and patients with stage I (n=9), II (n=9), III (n=15), and IV (n=4) HGSOC. All plots are presented as 40 minus the cycle threshold (40-Ct). (D) ROC curves for distinguishing all HGSOC cases from controls (patients with no symptoms or benign ovarian masses) using Mercy Halo and CA125 ELISA. (E) ROC curves for distinguishing early-stage HGSOC cases from controls.
Ca125 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Human+CA125%2FMUC16+Quantikine+ELISA+Kit/bio_rxiv__2023__02__07__527360-239-2-5
Average 94 stars, based on 1 article reviews
ca125 elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
human ca125 elisa kit  (R&D Systems)
92
R&D Systems human ca125 elisa kit
Analysis of tumour biomarkers (CEA and <t>CA125)</t> levels and the number of CTCs in serum at the time point of patient enrollment and 3 months after. A. Comparison of the concentration of CEA at the time point of patient enrollment and 3 months after in each group (# p < 0.05, ##p < 0.01, ** p < 0.01 ). B. Comparison of the concentration of CA125 at the time point of patient enrollment and 3 months after within each group (# p < 0.05 ). C. Comparison of CA125 change between each group ( * p < 0.05, ** p < 0.01 ). The left picture displays the difference of two groups (A&B vs C&D) according to the factor of “EGFR mutation”. The right picture displays the difference of two groups (A&C vs B&D) according to the factor of “NK cell infusion” positive or negative. D, E. Comparison of the CTC number at the time point of patient enrollment and 3 months after in each group ( # p < 0.05, ##p < 0.01, ** p < 0.01 ).
Human Ca125 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Human+CA125%2FMUC16+ELISA+Kit+(Colorimetric)/pmc08985770-107-16-20
Average 92 stars, based on 1 article reviews
human ca125 elisa kit - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier
human carbohydrate antigen 125 ca125  (Cusabio)
93
Cusabio human carbohydrate antigen 125 ca125
Analysis of tumour biomarkers (CEA and <t>CA125)</t> levels and the number of CTCs in serum at the time point of patient enrollment and 3 months after. A. Comparison of the concentration of CEA at the time point of patient enrollment and 3 months after in each group (# p < 0.05, ##p < 0.01, ** p < 0.01 ). B. Comparison of the concentration of CA125 at the time point of patient enrollment and 3 months after within each group (# p < 0.05 ). C. Comparison of CA125 change between each group ( * p < 0.05, ** p < 0.01 ). The left picture displays the difference of two groups (A&B vs C&D) according to the factor of “EGFR mutation”. The right picture displays the difference of two groups (A&C vs B&D) according to the factor of “NK cell infusion” positive or negative. D, E. Comparison of the CTC number at the time point of patient enrollment and 3 months after in each group ( # p < 0.05, ##p < 0.01, ** p < 0.01 ).
Human Carbohydrate Antigen 125 Ca125, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Human+Carbonhydrate+Antigen+125(CA125)+ELISA+Kit/pmc11220052-129-3-17
Average 93 stars, based on 1 article reviews
human carbohydrate antigen 125 ca125 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
ca19-9 elisa kit  (Abnova)
90
Abnova ca19-9 elisa kit
Validating the diagnostic value of AZGP1, CEA and <t> CA19-9 </t> and the combination by leave-one-out cross-validation.
Ca19 9 Elisa Kit, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/ca125++human++elisa+kit/pmc04307269-137-18-21
Average 90 stars, based on 1 article reviews
ca19-9 elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
733 human ca125  (Elabscience Biotechnology)
93
Elabscience Biotechnology 733 human ca125
Validating the diagnostic value of AZGP1, CEA and <t> CA19-9 </t> and the combination by leave-one-out cross-validation.
733 Human Ca125, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ca125+elisa+kit/Uncoated+Human+CA125+(CarbohydUncoated+Rate+Antigen+125)+ELISA+Kit/pm41198016-366-41-47
Average 93 stars, based on 1 article reviews
733 human ca125 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
human carbohydrate antigen ca 125 elisa kit  (OriGene)
N/A
Human Carbohydrate Antigen CA 125 ELISA kit
   Buy from Supplier
human ca-125 onestep elisa kit  (Boster Bio)
N/A
Sandwich High Sensitivity ELISA kit for Quantitative Detection of Human CA125. 96 wells/kit.
   Buy from Supplier
human ca125 muc16 elisa kit colorimetric  (Novus Biologicals)
N/A
The Human CA125 MUC16 ELISA Kit Colorimetric from Novus Biologicals is a ELISA Kit Colorimetric that quantifies human CA125 MUC16 in human serum plasma
   Buy from Supplier
human ca125 carbohydrate antigen 125 elisa kit  (Elabscience)
N/A
   Buy from Supplier
elisa kit ca 125 human  (G Biosciences)
N/A
An ELISA kit for the detection of CA 125 Human This uses Sandwich ELISA Double Antibody and has a sensitivity of 0 938U ml
   Buy from Supplier

Image Search Results


Serum CA125, HE4, and CA72-4 ELISA analyses in patients with OvEndo and CTR. Blood samples were collected from each patient group included in the study, OvEndo and CTR, in non-heparinized tubes and centrifugated. Serum samples concentrations were performed for each marker, CA125, HE4, and CA72-4. CA: Cancer antigen; CTR: Control; ELISA: Enzyme-linked immunosorbent assay; HE4: Human epididymis 4; OvEndo: Ovarian endometriosis

Journal: Romanian Journal of Morphology and Embryology

Article Title: The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis

doi: 10.47162/RJME.64.2.05

Figure Lengend Snippet: Serum CA125, HE4, and CA72-4 ELISA analyses in patients with OvEndo and CTR. Blood samples were collected from each patient group included in the study, OvEndo and CTR, in non-heparinized tubes and centrifugated. Serum samples concentrations were performed for each marker, CA125, HE4, and CA72-4. CA: Cancer antigen; CTR: Control; ELISA: Enzyme-linked immunosorbent assay; HE4: Human epididymis 4; OvEndo: Ovarian endometriosis

Article Snippet: The kits used were Human CA125 ELISA kit (Elabscience), Human HE4 ELISA kit (Wuhan Fine BioTech), and Human CA72-4 ELISA kit (ANOVA) (Figure ).

Techniques: Enzyme-linked Immunosorbent Assay, Marker, Control

Serum CA125, HE4, and CA72-4 levels in CTRs and OvEndo patients

Journal: Romanian Journal of Morphology and Embryology

Article Title: The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis

doi: 10.47162/RJME.64.2.05

Figure Lengend Snippet: Serum CA125, HE4, and CA72-4 levels in CTRs and OvEndo patients

Article Snippet: The kits used were Human CA125 ELISA kit (Elabscience), Human HE4 ELISA kit (Wuhan Fine BioTech), and Human CA72-4 ELISA kit (ANOVA) (Figure ).

Techniques:

(A–F) Expression levels of CA125, HE4, and CA72-4 serum markers in CTRs and OvEndo. AUC: Area under the curve; CA: Cancer antigen; CTR: Control; HE4: Human epididymis 4; OvEndo: Ovarian endometriosis; ROC: Receiver operating characteristic

Journal: Romanian Journal of Morphology and Embryology

Article Title: The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis

doi: 10.47162/RJME.64.2.05

Figure Lengend Snippet: (A–F) Expression levels of CA125, HE4, and CA72-4 serum markers in CTRs and OvEndo. AUC: Area under the curve; CA: Cancer antigen; CTR: Control; HE4: Human epididymis 4; OvEndo: Ovarian endometriosis; ROC: Receiver operating characteristic

Article Snippet: The kits used were Human CA125 ELISA kit (Elabscience), Human HE4 ELISA kit (Wuhan Fine BioTech), and Human CA72-4 ELISA kit (ANOVA) (Figure ).

Techniques: Expressing, Control

Performance of (A) Mercy Halo biomarker combination FOLR1/MUC16, (B) Mercy Halo biomarker combination BST2/FOLR1/MUC16, and (C) CA125 ELISA in a cohort of healthy controls (n=24), patients with benign ovarian masses (n=26), and patients with stage I (n=9), II (n=9), III (n=15), and IV (n=4) HGSOC. All plots are presented as 40 minus the cycle threshold (40-Ct). (D) ROC curves for distinguishing all HGSOC cases from controls (patients with no symptoms or benign ovarian masses) using Mercy Halo and CA125 ELISA. (E) ROC curves for distinguishing early-stage HGSOC cases from controls.

Journal: bioRxiv

Article Title: Colocalization of Cancer Associated Biomarkers on Single Extracellular Vesicles for Early Cancer Detection

doi: 10.1101/2023.02.07.527360

Figure Lengend Snippet: Performance of (A) Mercy Halo biomarker combination FOLR1/MUC16, (B) Mercy Halo biomarker combination BST2/FOLR1/MUC16, and (C) CA125 ELISA in a cohort of healthy controls (n=24), patients with benign ovarian masses (n=26), and patients with stage I (n=9), II (n=9), III (n=15), and IV (n=4) HGSOC. All plots are presented as 40 minus the cycle threshold (40-Ct). (D) ROC curves for distinguishing all HGSOC cases from controls (patients with no symptoms or benign ovarian masses) using Mercy Halo and CA125 ELISA. (E) ROC curves for distinguishing early-stage HGSOC cases from controls.

Article Snippet: A commercial CA125 ELISA kit (R&D SYSTEMS, Human CA125/MUC16 Quantikine ELISA kit, cat # DCA 125) was used to gauge the relative sensitivity and specificity of Mercy Halo.

Techniques: Biomarker Discovery, Enzyme-linked Immunosorbent Assay

Analysis of tumour biomarkers (CEA and CA125) levels and the number of CTCs in serum at the time point of patient enrollment and 3 months after. A. Comparison of the concentration of CEA at the time point of patient enrollment and 3 months after in each group (# p < 0.05, ##p < 0.01, ** p < 0.01 ). B. Comparison of the concentration of CA125 at the time point of patient enrollment and 3 months after within each group (# p < 0.05 ). C. Comparison of CA125 change between each group ( * p < 0.05, ** p < 0.01 ). The left picture displays the difference of two groups (A&B vs C&D) according to the factor of “EGFR mutation”. The right picture displays the difference of two groups (A&C vs B&D) according to the factor of “NK cell infusion” positive or negative. D, E. Comparison of the CTC number at the time point of patient enrollment and 3 months after in each group ( # p < 0.05, ##p < 0.01, ** p < 0.01 ).

Journal: Precision Clinical Medicine

Article Title: Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations

doi: 10.1093/pcmedi/pbz023

Figure Lengend Snippet: Analysis of tumour biomarkers (CEA and CA125) levels and the number of CTCs in serum at the time point of patient enrollment and 3 months after. A. Comparison of the concentration of CEA at the time point of patient enrollment and 3 months after in each group (# p < 0.05, ##p < 0.01, ** p < 0.01 ). B. Comparison of the concentration of CA125 at the time point of patient enrollment and 3 months after within each group (# p < 0.05 ). C. Comparison of CA125 change between each group ( * p < 0.05, ** p < 0.01 ). The left picture displays the difference of two groups (A&B vs C&D) according to the factor of “EGFR mutation”. The right picture displays the difference of two groups (A&C vs B&D) according to the factor of “NK cell infusion” positive or negative. D, E. Comparison of the CTC number at the time point of patient enrollment and 3 months after in each group ( # p < 0.05, ##p < 0.01, ** p < 0.01 ).

Article Snippet: Concentrations of serum carcinoembryonic antigen (CEA) and CA125 were measured with Human CEA ELISA Kit and Human CA125 ELISA Kit (R&D Systems, USA) following the manufacturer’s protocols.

Techniques: Comparison, Concentration Assay, Mutagenesis

Validating the diagnostic value of AZGP1, CEA and CA19-9 and the combination by leave-one-out cross-validation.

Journal: International Journal of Molecular Sciences

Article Title: Zinc-α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population

doi: 10.3390/ijms16010691

Figure Lengend Snippet: Validating the diagnostic value of AZGP1, CEA and CA19-9 and the combination by leave-one-out cross-validation.

Article Snippet: The serum concentrations of AZGP1, CEA and Carbohydrate 19-9 (CA19-9) were measured by commercially available AZGP1, CEA and CA19-9 ELISA kits (Abnova, Heidelberg, Germany) according to the manufacturer’s recommendations.

Techniques: Diagnostic Assay